Cost-Effectiveness and Outcome Optimization Strategies in the Treatment of Residual Cardiovascular Risk Beyond LDL Cholesterol in the Managed Care SettingByApril 2nd 2009
Beyond LDL Cholesterol: The Role of Elevated Triglycerides and Low HDL Cholesterol in Residual CVD Risk Remaining After Statin TherapyByPeter Alagona Jr, MD, FACCMarch 27th 2009
The Impact of Residual CVD Risk in the Managed Care SettingByMark J. Cziraky, PharmD, CLS, FAHAMarch 27th 2009
